MX5535E - PROCEDURE FOR PREPARING 2-ALPHA-CIANO-3-OXO-STEROIDS - Google Patents

PROCEDURE FOR PREPARING 2-ALPHA-CIANO-3-OXO-STEROIDS

Info

Publication number
MX5535E
MX5535E MX787593U MX759378U MX5535E MX 5535 E MX5535 E MX 5535E MX 787593 U MX787593 U MX 787593U MX 759378 U MX759378 U MX 759378U MX 5535 E MX5535 E MX 5535E
Authority
MX
Mexico
Prior art keywords
ciano
steroids
oxo
alpha
preparing
Prior art date
Application number
MX787593U
Other languages
Spanish (es)
Inventor
Robert George Christiansen
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of MX5535E publication Critical patent/MX5535E/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048Alkynyl derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0063Nitrogen and oxygen at position 2(3)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MX787593U 1977-12-20 1978-12-14 PROCEDURE FOR PREPARING 2-ALPHA-CIANO-3-OXO-STEROIDS MX5535E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/862,417 US4160027A (en) 1977-12-20 1977-12-20 Steroid cyanoketones and intermediates

Publications (1)

Publication Number Publication Date
MX5535E true MX5535E (en) 1983-09-27

Family

ID=25338450

Family Applications (1)

Application Number Title Priority Date Filing Date
MX787593U MX5535E (en) 1977-12-20 1978-12-14 PROCEDURE FOR PREPARING 2-ALPHA-CIANO-3-OXO-STEROIDS

Country Status (27)

Country Link
US (1) US4160027A (en)
JP (2) JPS5488253A (en)
AR (1) AR222645A1 (en)
AT (1) AT367070B (en)
AU (1) AU518997B2 (en)
BE (1) BE872886A (en)
CA (1) CA1121340A (en)
CH (1) CH637409A5 (en)
DE (1) DE2855091A1 (en)
DK (1) DK156727C (en)
ES (1) ES476117A1 (en)
FI (1) FI66010C (en)
FR (1) FR2412569A1 (en)
GB (2) GB2088878B (en)
HK (1) HK89287A (en)
IE (1) IE48076B1 (en)
IL (1) IL56076A (en)
IT (1) IT1195258B (en)
LU (1) LU80673A1 (en)
MX (1) MX5535E (en)
NL (1) NL190848C (en)
NO (1) NO151467C (en)
NZ (1) NZ189035A (en)
PH (2) PH14778A (en)
PT (1) PT68926A (en)
SE (1) SE433221B (en)
ZA (1) ZA786746B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4349474A (en) * 1981-07-27 1982-09-14 G. D. Searle & Co. 2-Cyanosteroids
ES8504486A1 (en) * 1982-11-02 1985-05-01 Sterwin Ag Steroid compounds.
DK23984A (en) * 1983-02-11 1984-08-12 Hoffmann La Roche D-homosteroids
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
GB8404980D0 (en) * 1984-02-25 1984-03-28 Sterwin Ag Steroid compound
DE3531903A1 (en) * 1985-09-05 1987-03-12 Schering Ag OXYTOCIN AND ANTI-DAYS FOR THE INTRODUCTION OF BIRTH OR ON THE THERAPEUTIC STOP OF GRAVIDITY
US4755595A (en) * 1985-11-01 1988-07-05 Sterling Drug Inc. Enhanced production of 4,5-unsaturated steroids utilizing methanol solvation
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
US4870068A (en) * 1986-05-22 1989-09-26 Sterling Drug Inc. Method of regulating fertility in swine using epostane
US5795881A (en) * 1987-06-16 1998-08-18 Schering Aktiengesellschaft Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
US5215978A (en) * 1989-06-16 1993-06-01 The Upjohn Company Method of enhancing egg laying in turkeys using epostane
JPH0538929A (en) * 1991-08-02 1993-02-19 Mitsubishi Heavy Ind Ltd Air conditioner for vehicle
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
EP2468282A3 (en) * 2005-07-12 2012-09-12 DMI Biosciences, Inc. Methods and products for treatment of diseases
SG2014008171A (en) * 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
US20100323991A1 (en) * 2009-06-22 2010-12-23 Dmi Acquisition Corp. Methods and products for treatment of diseases
SG10201705044YA (en) 2012-12-19 2017-07-28 Ampio Pharmaceuticals Inc Method for treatment of diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296255A (en) * 1963-11-29 1967-01-03 Sterling Drug Inc 2-cyano steroids
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound

Also Published As

Publication number Publication date
AU4208978A (en) 1979-06-28
FR2412569A1 (en) 1979-07-20
JPS62142198A (en) 1987-06-25
DK156727C (en) 1990-03-12
PH14778A (en) 1981-12-09
JPS6220998B2 (en) 1987-05-11
FI783901A (en) 1979-06-21
PH16835A (en) 1984-03-15
FR2412569B1 (en) 1982-05-28
IL56076A0 (en) 1979-01-31
NO784281L (en) 1979-06-21
GB2088878B (en) 1983-01-19
AU518997B2 (en) 1981-10-29
GB2010278A (en) 1979-06-27
AT367070B (en) 1982-05-25
DK569678A (en) 1979-06-21
HK89287A (en) 1987-12-11
US4160027A (en) 1979-07-03
GB2088878A (en) 1982-06-16
SE7813067L (en) 1979-06-21
AR222645A1 (en) 1981-06-15
ATA888578A (en) 1981-10-15
NL190848B (en) 1994-04-18
JPS5488253A (en) 1979-07-13
IT7831011A0 (en) 1978-12-19
JPS6361314B2 (en) 1988-11-28
CA1121340A (en) 1982-04-06
NO151467B (en) 1985-01-02
LU80673A1 (en) 1979-07-20
FI66010C (en) 1984-08-10
DE2855091C2 (en) 1988-12-22
SE433221B (en) 1984-05-14
FI66010B (en) 1984-04-30
CH637409A5 (en) 1983-07-29
NZ189035A (en) 1980-08-26
NL7812309A (en) 1979-06-22
PT68926A (en) 1979-01-01
DK156727B (en) 1989-09-25
NL190848C (en) 1994-09-16
NO151467C (en) 1985-04-17
ES476117A1 (en) 1979-11-16
BE872886A (en) 1979-06-20
GB2010278B (en) 1982-10-20
IE782492L (en) 1979-06-20
IE48076B1 (en) 1984-09-19
IT1195258B (en) 1988-10-12
IL56076A (en) 1983-06-15
DE2855091A1 (en) 1979-06-28
ZA786746B (en) 1979-11-28

Similar Documents

Publication Publication Date Title
MX5449E (en) PROCEDURE FOR PREPARING HYDROXIDIPHOSPHONIC ACIDS
AR231131A1 (en) PROCEDURE FOR PREPARING ACILUREIDOALQUIL-BENCENSULFONILUREAS
MX154095A (en) PROCEDURE FOR PREPARING SILILED POLYETERS
IT1101294B (en) PROCEDURE FOR PREPARING NTIRODIARILAMMINE
ES492255A0 (en) PROCEDURE FOR PREPARING AROILIMIDAZOLE-2-ONAS
MX4652E (en) PROCEDURE FOR PREPARING ARIL-3-OXAZOLIDINONES-2
MX150757A (en) IMPROVED PROCEDURE FOR PREPARING ZEOLITE
MX5535E (en) PROCEDURE FOR PREPARING 2-ALPHA-CIANO-3-OXO-STEROIDS
IT1097295B (en) PROCEDURE FOR PREPARING P-BENZOKINONE
MX4883E (en) PROCEDURE FOR PREPARING AMIDINOUREAS
MX147874A (en) PROCEDURE FOR PREPARING COMPOUNDS 2-PHENOXY-5-TRIFLUOROMETILPIRIDINA
MX4597E (en) PROCEDURE FOR PREPARING GAMMA-PIRONAS
IT1092403B (en) PROCEDURE FOR PREPARING PROTOCATECUALDEIDE
MX151851A (en) IMPROVED PROCEDURE FOR PREPARING TRIACINE DERIVATIVES
AR219549A1 (en) PROCEDURE FOR PREPARING RIFAMPICINE
MX4594E (en) PROCEDURE FOR PREPARING 3-HALOMETILCEFEM COMPOUNDS
AR222453A1 (en) PROCEDURE FOR PREPARING 3-AMINO-4-CARBOXY-THIOPHENES
MX6024E (en) PROCEDURE FOR PREPARING 2-CHLORINE-4-HYDROXYMETHYL-THIAZOLES-5-SUBSTITUTED
IT1089268B (en) PROCEDURE FOR PREPARING METHYL-ISOCYANATE
MX5434E (en) PROCEDURE FOR PREPARING CYCLOPROFILCARBOXYLATES
MX5160E (en) IMPROVED PROCEDURE FOR PREPARING AMINOALCOHOLE DERIVATIVES
MX4711E (en) PROCEDURE FOR PREPARING DERIVATIVES-BE-N- (1-ALIL-2-PIRROLIDILMETIL) -2-3-DIMETOXI-5-SULFAMOILBENZAMIDA
MX5208E (en) PROCEDURE FOR PREPARING DICLOROVINILCICLOBUTANONAS
MX4779E (en) PROCEDURE FOR PREPARING DI-N-PROPYLLA-KETONITRILE
MX4568E (en) PROCEDURE FOR PREPARING DI-N-PROPYLACETANIDE